Circulation

OCT 19, 2026 · JOURNAL ARTICLE

Radiation Vasculopathy of the Coronary Arteries: State-of-the Art Review

Circulation

Radiation-associated coronary artery disease (RACAD) is a distinct form of coronary artery disease with several specific biological and clinical aspects as well as key knowledge ga

OCT 12, 2026 · JOURNAL ARTICLE

Cardiovascular Complications of Chronic Liver Disease

Circulation

Chronic liver disease is an increasingly prevalent and heterogeneous syndrome with important consequences for cardiovascular function. As the global burdens of chronic liver diseas

OCT 5, 2026 · JOURNAL ARTICLE

Anticancer Drugs and Cancer-Associated Thrombosis

Circulation

The rapid development of novel cancer therapies has considerably improved the care of cancer patients and cancer-related survival; however, these therapies are associated with a br

SEP 29, 2026 · JOURNAL ARTICLE

The Association Between Hospital Comprehensive Stroke Center Designation Status and Stroke Rate Reporting in the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry After Transcatheter Aortic Valve Replacement: Implications for Hospital Performance Assessment

Circulation

BACKGROUND: The Michigan Structural Heart Consortium showed that transcatheter aortic valve replacement (TAVR) stroke rates were associated with hospital Comprehensive Stroke Cente

SEP 15, 2026 · JOURNAL ARTICLE

State of Cardiovascular Disease and Stroke in Hispanic/Latino Adults in the United States: A Scientific Statement From the American Heart Association

Circulation

Cardiovascular disease became the leading cause of death among Hispanic individuals in the United States in 2022. Hispanic adults experience a disproportionate burden of cardiometa

AUG 25, 2026 · JOURNAL ARTICLE

Dual-Target Cardiac Regeneration: Controllable Nfyb/Nr3c1 Cointervention Spurs Cardiomyocyte Cytokinesis After Myocardial Infarction

Circulation

Preclinical mechanistic study in transgenic mice and engineered tissues identifying a dual regulatory pathway; no clinical trials, hard outcomes, or direct human translation reported.